The University of Liverpool (UoL) was founded in 1881, and has a long history of collaboration with other research-intensive institutions. Its alumni include nine Nobel Peace prize winners, and it is currently ranked in the top 1% of universities worldwide. It is home to 33,000 students, including those studying at the Liverpool School of Medicine, which predates the University itself, and which is one of the largest medical schools in the UK. The University is home to many collaborative scientific Centres of Excellence, including the North West Cancer Research Centre, the North West Hub for Trials Methodology and the Wellcome Liverpool Glasgow Centre for Global Health Research.

UoL AMBITION Team

Prof. William Hope: Senior Investigator

I am Professor of Therapeutics and Infectious Diseases at the University of Liverpool in the UK, a Fellow of the Royal Australasian College of Physicians and a Fellow of the Royal College of Pathologists of Australasia. I lead the newly formed Centre for Antimicrobial Pharmacodynamics, and my research interests focus upon antimicrobial pharmacokinetics and pharmacodynamics, antimicrobial drug development and individualisation of antimicrobial therapy.

I work closely with Dr. Kat Stott on the PK/PD analyses of AMBITION trial samples.

Dr. Kat Stott: Clinical Research Fellow

I am a specialist medical registrar in clinical pharmacology and therapeutics. I am undertaking a Wellcome Trust-funded PhD through UoL, but am based in Blantyre until spring 2019. My PhD will investigate the mechanism of action of abbreviated amphotericin B in the treatment of cryptococcal meningitis and will include a pharmacokinetic/ pharmacodynamic sub-study of the AMBITION trial.